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Membrane trafﬁcIntegrin signaling is central to cell growth and differentiation, and critical for the processes of apoptosis, cell
migration and wound repair. Previous research has demonstrated a requirement for SNARE-dependent
membrane trafﬁc in integrin trafﬁcking, as well as cell adhesion and migration. The goal of the present
research was to ascertain whether SNARE-dependent membrane trafﬁcking is required speciﬁcally for
integrin-mediated signaling. Membrane trafﬁc was inhibited in Chinese hamster ovary cells by expression of
dominant-negative (E329Q) N-ethylmaleimide-sensitive fusion protein (NSF) or a truncated form of the
SNARE SNAP23. Integrin signaling was monitored as cells were plated on ﬁbronectin under serum-free
conditions. E329Q-NSF expression inhibited phosphorylation of focal adhesion kinase (FAK) on Tyr397 at
early time points of adhesion. Phosphorylation of FAK on Tyr576, Tyr861 and Tyr925 was also impaired by
expression of E329Q-NSF or truncated SNAP23, as was trafﬁcking, localization and activation of Src and its
interaction with FAK. Decreased FAK–Src interaction coincided with reduced Rac activation, decreased focal
adhesion turnover, reduced Akt phosphorylation and lower phosphatidylinositol 3,4,5-trisphosphate levels in
the cell periphery. Over-expression of plasma membrane-targeted Src or phosphatidylinositol 3-kinase
(PI3K) rescued cell spreading and focal adhesion turnover. The results suggest that SNARE-dependent
trafﬁcking is required for integrin signaling through a FAK/Src/PI3K-dependent pathway.M, extracellular matrix; FN,
inase; NSF, N-ethylmaleimide-
ase; PIP3, phosphatidylinositol
tein receptor
1; fax: +1 519 837 1802.
lino).
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Adhesive interactions between cells and extracellular matrix
(ECM) components such as ﬁbronectin (FN) are mainly dependent
on integrins which serve to link the ECM to intracellular signaling and
the cytoskeleton. This link is critical for the initiation andmaintenance
of a variety of signaling pathways leading to cell motility, differen-
tiation and survival. Upon engagement, integrins cluster and assemble
a variety of intracellular proteins at focal adhesions (FA). An essential
protein for FA assembly, turnover and signaling is a nonreceptor
protein-tyrosine kinase, focal adhesion kinase (FAK), which binds and
phosphorylates a variety of signaling and adaptor proteins, such as
Src, p130Cas, paxillin and phosphatidylinositol 3-kinase (PI3K).
Several lines of investigation indicate that it is the FAK–Src complex
that controls FA turnover, cell morphology, motility and survival [1,2].
As FAK is activated upon clustering at FAs, it autophosphorylates
Tyr397, creating a binding site for SH2 domains of several proteins, inparticular Src [3]. Src binding to FAK facilitates the transphosphoryla-
tion and activation of Src on Tyr416 and multiple FAK tyrosine
residues. Phosphorylation of FAK increases FAK kinase activity and
binding of other signaling and/or adaptor proteins, eventually leading
to the formation of Rac-dependent lamellipodia and turnover of FAs
through an as yet ill-deﬁned mechanism.
Src is a myristoylated, non-palmitoylated member of the Src-family
of protein-tyrosine kinases that localizes to the plasma membrane and
to a perinuclear compartment [4]. Evidence indicates that inactive Src
localizes to a perinuclear compartment, and translocates to the plasma
membrane and FAswhere it is activated. In cells expressing a dominant-
negative Rab11 protein, Src is retained in an inactive state in a
perinuclear compartment [5]. This localization of Src appears to be
separate from emerging roles for Src in regulating cargo sorting and
actin polymerization during vesicular transport [6,7].
During intracellular membrane trafﬁcking, vesicle movement
between compartments of the cell is controlled by the SNARE (soluble
NSF [N-ethylmaleimide-sensitive factor] attachment protein recep-
tor) family of membrane proteins. SNAREs can be classiﬁed into two
sub-families: vesicle-SNAREs (v-SNAREs, found on the vesicles) and
target-SNAREs (t-SNAREs, found on target membranes). Upon
trafﬁcking of a vesicle to a target membrane, v-SNAREs and t-SNAREs
form cytoplasmic coiled-coil trans-SNARE complexes bridging the
two membranes bringing them into proximity and facilitating fusion.
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ATPase, NSF, and its adaptor protein α-SNAP (soluble NSF attachment
protein) allowing recycling of SNAREs. NSF function is required to
disassemble SNARE complexes, thus inhibition of NSF can act as a
global inhibitor of membrane trafﬁcking [8].
Previous work from our laboratory has shown that SNARE-
mediated membrane trafﬁc is required for integrin trafﬁcking,
lamellipodium extension, cell migration, and maintenance of normal
FAs [9–11]. These are phenotypes seen in FAK−/− cells suggesting that
membrane trafﬁc may have a role in integrin–FAK signaling. In the
present study, we report that inhibition of SNARE-mediated mem-
brane trafﬁc obstructs Src translocation from a Rab11-containing
recycling compartment to the plasma membrane, perturbing inter-
action with FAK and inhibiting FAK–Src dependent signaling. This
results in reduced cell spreading and FA turnover. Expression of a
plasma membrane-targeted Src and p110-subunit of PI3K rescues cell
spreading and FA turnover. Our ﬁndings suggest that SNARE-
mediated trafﬁc plays a key role in signaling downstream of integrins
and modulates cell motility principally by controlling a FAK–Src
signaling complex.
2. Experimental procedures
2.1. Reagents and cDNA constructs
All chemicals were purchased from Sigma Chemical Co. (St. Louis,
MO) or Fisher Scientiﬁc (Nepean, ON) unless otherwise indicated.
Antibodies were obtained against NSF from Stressgen Biotechnologies
(Victoria, BC), Rab11, phosphoTyr397-FAK and mouse anti-FAK
(F15020) from BD Biosciences (Mississauga, ON), rabbit anti-FAK from
Abcam (ab40794; Cambridge, MA), phosphoTyr576-FAK from Novus
Biologicals (Littleton, CO), phosphoTyr925-FAK and phosphoSer473-
Akt from Cell Signaling Technology, Inc. (Boston, MA), phosphoTyr418-
Src, phosphoTyr861-FAK and Src from Applied Biological Materials, Inc.
(Richmond, BC), α-tubulin from Invitrogen, Co. (A11126; Mississauga,
ON), and Rac from Cytoskeleton, Inc. (Denver, CO). The pcDNA3.1,
pcDNA3.1-SNAP23ﬂ, and pcDNA3.1-SNAP23CΔ9, were kind gifts from
Dr. W.S. Trimble (Hospital for Sick Children, Toronto, ON). The pEGFP-
SNAP23CΔ9 andpEGFP-SNAP23ﬂ constructswere generatedby inserting
the XhoI/EcoRI fragment from the full-length and truncated pcDNA3.1-
SNAP23, respectively, into peGFP-C1. The FLAG-SNAP23 constructs
were generated by subcloning the full-length SNAP23 into pcDNA3.1-
FLAG, a kind gift from Dr. Nina Jones (University of Guelph, Guelph,
Canada). The pERFP-PH-Akt was a kind gift from Dr. M. Skinner
(University of Guelph, Guelph, ON). The generation of pcDNA3.1–wild-
typeNSF andE329Q-NSF constructs is described elsewhere [9]. GFP-FAK
was provided by Dr. L.H. Tsai (MIT, Cambridge, MA). GFP-talin was a
kind gift of Dr. A. Huttenlocher (University of Wisconsin, Madison,WI).
The pEGFP-Rab11 and Rab11S25N constructs were kind gifts of Dr.
John Brumell (Hospital for Sick Children, Toronto, ON). The pcDNA3.1-
PI3K-CAAX was obtained from Addgene, Inc [Addgene plasmid 12591]
[12]. pUSEamp containing wild-type Src and a C-terminal truncated
constitutively active Src were kind gifts of Dr. Nina Jones (University of
Guelph, Guelph, ON). Themembrane-targeted Src-CAAXwas generated
by PCR from pUSEamp-SrcWT using Src-CAAX forward (5′-ataactcga-
gatgggcagcaacaagagc-3′), Src-CAAX reverse (5′-ataaaagaattctcaca-
taactgtacaccttgtccttgataggttctccccgggctggtact-3′) primers followed by
cloning into pcDNA3.1(−).
2.2. Cell culture and transfection
Chinese hamster ovary (CHO)-K1 or CHO cells expressing E329Q-
NSF under an inducible promoter [CHO-E329Q; TeT-ON, BD Bios-
ciences, Mississauga, ON; described elsewhere [9]] were grown in
Dulbecco's modiﬁed Eagle's medium (DMEM) supplemented with
10% (v/v) fetal bovine serum at 37 °C and 5% (v/v) CO2. Cells weretransfected using FuGENE6 transfection reagent following the
manufacturer's suggested protocol (Roche Applied Science, Laval,
QC) or calcium phosphate-DNA precipitation. DNA complexes were
incubated on the cells for 15 h with the SNAP23 and Rab11S25N
constructs, 9 h when transfecting with NSF containing plasmids, or
4–6 h prior to induction of E329Q-NSF when using pERFP-PH-Akt or
Src constructs (total expression 13–17 h). Co-transfection studies
were performed at a 10:1 molar ratio of DNA-to-marker DNA.
2.3. Immunoﬂuorescence assays
To monitor spreading or FA formation, CHO-K1 cells were
transfected, lifted and plated onto FN-coated (10 μg/mL—FA forma-
tion; 20 μg/mL—lamellipodia extension) glass coverslips, washed
with PBS and ﬁxed with 4% paraformaldehyde (w/v)/PBS. To monitor
Src and PIP3 localization, CHO-E329Q cells were induced with 2 μg/mL
doxycycline or mock treated for 9 h, lifted and plated on FN
(20 μg/mL) coated coverslips and allowed to adhere, followed by
ﬁxation in ice-cold 0.1% Triton X-100 (v/v), 2% paraformaldehyde (w/v)
inPBSat4 °C for 30 minwith shaking. Sampleswere thenpermeabilized
and blocked before staining with primary and secondary antibody,
and/or rhodamine-phalloidin (Invitrogen,Mississauga, ON) followed
by washing and mounting. Samples were imaged using a 40× or 63×
(NA 1.4) lens on a Leica DM-IRE2 inverted microscope with a Leica
TCS SP2 system (Leica, Heidelberg, Germany). Images were captured
and 3D reconstructions were performed using Leica Confocal Software
package. Lamellipodium extension and FA size were assessed in ImageJ
software as described elsewhere [10,11]. For Src trafﬁcking assays, cells
adherent for 15 or 60 min were visually scored as having primarily
peripheral or perinuclear Src staining.
For live cell imaging, CHO cells were transfected, lifted in serum-
and phenol red-free DMEM/F12 (Gibco, Missisauga, ON) supplemen-
ted with 15 mM HEPES, pH 7.4, plated on FN-coated coverslips for
90 min. Then the coverslips were inserted in a Series 40 chamber in a
QE-1 heated platform (Harvard Apparatus Canada, Saint-Laurent, QC),
sealed on top with a coverslip and mounted on the microscope stage.
Temperature was maintained at 37 °C with a TC-324B temperature
controller (Harvard Apparatus Canada, Saint-Laurent, QC). Images
were acquired every 30–60 s for approximately 30 min. Time series
were imported into ImageJ software for processing.
2.4. Immunoprecipitation and Western blotting
CHO-E329Q cells were induced with 2 μg/mL doxycycline or mock
treated (DMSO alone) for 9 h, or co-transfected with GFP-FAK and
pcDNA3.1-SNAP23ﬂ or pcDNA3.1-SNAP23CΔ9 for 15 h, the last hour of
which the cells were serum-starved. Cells were lifted and equal
numbers were held in suspension for 15 min or plated on FN for the
indicated times. For phosphoprotein probing, cells were lysed in situ
in SDS sample buffer containing 20 μg/mL DNAase and equal volumes
of lysate were analyzed by Western blotting. For immunoprecipita-
tions, cells were harvested and lysed in 50 mM Tris–HCl, pH 7.5,
150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 2 mM sodium
ﬂuoride, 2 mM sodium vanadate (lysis buffer) and Sigma complete
protease inhibitor cocktail. Lysates were pre-cleared and supernatants
containing 1 mg of protein were incubated with FAK (BD Biosciences,
Mississauga, ON) or GFP antibody (Abcam, Cambridge, MA) immo-
bilized on Protein G-Sepharose 4B beads (Sigma, Oakville, ON) for
overnight. The beads werewashed three timeswith lysis buffer before
elution with hot 2× Laemmli buffer for SDS-PAGE/Western blot
analysis of Src. Antibody complexes were detected by ECL Plus
chemiluminescence (GE Healthcare, Baie d'Urfe, QC). Where appro-
priate membranes were stripped (62.5 mM Tris–HCl, pH 6.8, 2% SDS
and 100 mM β-mercaptoethanol) for 15 min at 50 °C, washed
extensively and re-probed for FAK.
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RacGTP pull-down and analysis were done using a kit from
Cytoskeleton, Inc. (BK035;Denver, CO)using themanufacturer'sprotocol.
2.6. Cell fractionation
CHO-E329Q cells were induced with 2 μg/mL doxycycline or mock
treated for 9 h, the last hour of which the cells were serum-starved.
Cells were lifted held in suspension for 15 min or plated on FN for the
indicated times. Cells were lysed in situ in homogenization buffer
(50 mM HEPES, pH 7.4, 50 mM NaCl, 1 mMMgCl2, 2 mM EDTA, 1 mM
DTT, Sigma protease inhibitor cocktail), lysates were collected
with scraping on ice and homogenized by 6–8 passage through a 21
gauge needle. Lysates were centrifuged at 500 g for 10 min to remove
unbroken cells then the supernatant centrifuged for 20 min at 500,000 g
to obtain a cytosolic fraction and a membrane-pellet fraction. The
membrane fraction was resuspended in Laemmli sample buffer and
samples were analyzed by SDS-PAGE–western blot for Rac1, Src or β1-
integrin.
3. Results
3.1. Inhibition of SNARE-mediated membrane trafﬁc impairs focal
adhesion turnover
Previously, we have shown that inhibition of SNARE-mediated
membrane trafﬁcking with dominant-negative NSF (E329Q-NSF) and
truncated SNAP23 (SN23CΔ9) impairs CHO spreading and causes the
formation of enlarged focal adhesions (FA) [11]. This was demonstrated
using GFP-paxillin to monitor FAs and here we expand upon this
approach using GFP-FAK and GFP-talin. CHO cells were co-transfected
with either GFP-FAK or GFP-talin, along with wild-type NSF (wtNSF),
E329Q-NSF, SNAP23 (SN23FL), truncated SN23CΔ9 or control vector. FA
sizedwas thenmeasured following adhesion to FN for 2 h. As previously
foundwith paxillin, inhibition ofmembrane trafﬁckingwith E329Q-NSF
and SN23CΔ9 resulted in GFP-FAK- and GFP-talin-containing FAs that
were between 40% and 70% larger than those found in control cells
(Fig. 1A). Expression of wtNSF and SN23FL had little effect on FA size
(Fig. 1A). Similar results were seen when endogenous proteins were
stained by indirect immunoﬂuorescence (data not shown). To deter-
mine if these FAs were larger because of a defect in FA turnover, FA
dynamics were monitored in real time following adhesion to FN. GFP-
paxillin was used for imaging FAs in live cells because of the clear signal
it provides when incorporated into FAs. In control cells expressing
wtNSF, GFP-paxillin containing FAs form, disassemble and appear to
move along stress ﬁbers—indicative of robust FA turnover (Fig. 1B;
Supplementary video1). In cells expressingE329Q-NSF, FAs assemble as
cells adhere, but rarely disassemble or move along stress ﬁbers (Fig. 1B;
Supplementary video 2).
3.2. SNARE-mediated trafﬁc is required for FAK phosphorylation and
interaction with Src
The observed inhibition of cell spreading and enlargement of FAs
(Section 3.1) may be explained by a defect in integrin signaling. In
cases where key FA proteins, such as FAK, and Src-family kinases, have
been knocked out or expression knocked down, cells have been
shown to spread and migrate poorly, and to contain enlarged FAs due
to a lack of FA turnover [13–15]. In several studies it has been shown
that the association of FAK and Src, and the subsequent phosphor-
ylation of FAK on several key residues, are crucial to maintaining cell
motility and FA turnover [16]. Biochemical analyses of FAK and
proteins with which FAK interacts are inefﬁcient using mixed
populations of cells obtained through transient transfection. To
avoid this inefﬁciency, phosphorylation of FAK and FAK binding ofSrc were assessed in CHO cells that contain a stably integrated E329Q-
NSF under the control of a doxycycline-inducible promoter (TeT-ON
system). These cells have been described previously (12) and allow
acute inhibition of SNARE-mediate membrane trafﬁc, uniformly in a
population of cells. The cells were induced to express E329Q-NSF (+),
or mock treated (−), serum-starved for 1 h (to minimize growth
factor-induced signaling), lifted and plated on FN for the times
indicated in Fig. 2A. Cells held in suspension for 15 min served as
negative controls (Susp). In cells not treated with doxycycline,
phosphorylation on Tyr416 of Src and Tyr397 of FAK could be
detected within 15 min of adhesion to FN. Phosphorylation at these
sites rose modestly during the ﬁrst 30 min of adhesion, but leveled off
by 45 min. In contrast to this, cells expressing E329Q-NSF showed
reduced phosphorylation on Tyr416 of Src at all time points and
reduced phosphorylation of FAK Tyr397 at 15 and 30 min (Fig. 2A). By
45 min, phosphorylation of FAK Tyr397 had recovered, suggesting
that FAK was being incorporated into FAs and that clustering of FA
components was inducing FAK autophosphorylation. FAK phosphor-
ylation sites dependent on Src activity [Tyr576 [17], Tyr861 [18] and
Tyr925 [19]], however, showed decreased phosphorylation at all
points during adhesion (Fig. 2A). These observations were made
repeatedly and quantiﬁcation of replicate western blots is shown in
Fig. 2B.
Expression of dominant-negative NSF is predicted to cause an
inhibition of all SNARE-mediatedmembrane trafﬁc. Tomore speciﬁcally
probe the role of SNARE-dependent trafﬁc in FAK signaling, we
disrupted the function of SNAP23 using SNAP23CΔ9 as described for
Fig. 1. CHO-K1 cells were co-transfected with the SNAP23CΔ9 construct
and GFP-FAK, and the phosphorylation of FAKwas monitored as above.
Expression of SNAP23CΔ9 did not inﬂuence phosphorylation of FAK
Tyr397, but did disrupt phosphorylation of FAK Tyr576, Tyr861 and
Tyr925 (Fig. 3). The blot shown in Fig. 3A is representative of several
replicates, the quantiﬁcation of which is shown in Fig. 3B. The results
suggest that inhibition of SNARE-mediated trafﬁc, generally with
dominant-negative NSF or speciﬁcally by inhibiting SNAP23, perturbs
ECM-induced phosphorylation of FAK.
The effect that inhibiting NSF has on the phosphorylation of Src
and FAK (Fig. 2) suggests that Src may not be binding FAK when
membrane trafﬁc is inhibited. To test this, FAK was immunoprecipi-
tated from control cells and E329Q-NSF-expressing cells, either held
in suspension or allowed to adhere to FN for 15 and 90 min (Fig. 4A).
In control cells, Src precipitated with FAK under adherent conditions,
but did not do so when cells were in suspension—as reported
previously [3,20]. In E329Q-NSF-expressing cells, Src failed to
efﬁciently precipitate with FAK when cells were adherent or
suspended. Similarly, when SNAP23CΔ9 was co-expressed with GFP-
FAK, little Src co-precipitated with GFP-FAKwhen cells were adherent
or suspended (Fig. 4B). Taken together, these results indicate that
inhibition of SNARE-mediated membrane trafﬁcking in CHO cells
prevents FAK–Src interaction.
3.3. Inhibition of SNARE-mediated trafﬁc traps Src in a Rab11 compartment
Src is membrane associated via a cotranslational myristoylation at
Gly2 and it is generally thought to be located on the cytoplasmic face
of the plasma membrane where it is free to interact with FAK, but
there is signiﬁcant evidence that Src can also be found on a variety of
intracellular membranes, in particular the recycling endosome [5].
These intracellular compartments may serve as a reservoir from
which Src is trafﬁcked to the plasma membrane. Src localization
during spreading was examined to determine if E329Q-NSF was
trapping Src in an intracellular compartment. It was determined
that at the onset of adhesion (15 min after plating on FN) a large
component of membrane-associated Src localized to a perinuclear
Rab11-containing compartment. This was the case in untreated cells
(Fig. 5M), wtNSF-expressing cells and E329Q-NSF-expressing cells
Fig. 1. Inhibition of SNARE-mediated membrane trafﬁc inhibits focal adhesion turnover. A. CHO-K1 cells were transiently co-transfected with either empty vector (pcDNA3.1), wild-
type NSF (WT-NSF), dominant-negative NSF (E329Q-NSF), full-length SNAP23 (SN23FL) or truncated SNAP23 (SN23CΔ9) along with either GFP-tagged FAK (GFP-FAK) or GFP-tagged
talin (GFP-talin) for 9 h, lifted and plated on ﬁbronectin (10 μg/mL) for 2 h. Cells were ﬁxed, imaged and focal adhesion size was measured using ImageJ software. Results are the
means±SEM of at least 3 separate experiments in which at least 10 cells were analyzed. B. CHO-K1 cells were transiently co-transfected with GFP-paxillin and either wild-type NSF
or dominant-negative NSF for 9 h, plated on FN-coated coverslips (10 μg/mL) for 1.5 h, then FAs containing GFP-paxillin were imaged every 30 s for 30 min. Time series were
imported into ImageJ for processing. Images are representative of at least 5 separate experiments. Arrowheads in the top row point to FAs, present at 90 min that subsequently
disappear. Arrowheads in the bottom row point to examples of persistent FAs. Scale bar=10 μm.
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Src is found both in a central Rab11-containing compartment and in
locations in the cell periphery (Fig. 5A–C). As control cells spread
(60 min time point), Src redistributes from the central compartment
to predominantly the cell periphery (Fig. 5G–I). In E329Q-NSF-
expressing cells, much of the Src remains in the central Rab11-
containing compartment, even at 60 min (Fig. 5J–L). Similar results
were observed when SNAP23 function was inhibited by expression of
SNAP23CΔ9 (micrographs not shown, quantiﬁcation shown in
Fig. 5M). Fig. 5M shows results from replicate experiments where
the percentage of cells containing Src in the perinuclear compartment
has been quantiﬁed in ﬂuorescent micrographs. These differences in
Src localization were not the result of dissimilar amounts of Src
associated with cellular membranes in wild-type- and E329Q-NSF-
expressing cells. As shown in Supplementary Fig. 1, there were no
signiﬁcant differences in the amount of membrane-bound Src
between control and E329Q-NSF-expressing cells.To determine if the trafﬁcking of Src out of the Rab11-containing
compartment was dependent on Rab11 function, we examined
trafﬁcking of Src in cells transfected with a dominant-negative form of
Rab11 (Rab11S25N). Similarly to E329Q-NSF, expression of Rab11S25N
inhibited trafﬁcking of Src out of the perinuclear compartment
(Fig. 5M), while wild-type Rab11 had no effect (data not shown). This
effect is consistent with previously published studies of the Rab11-
dependence of Src trafﬁcking [5]. These ﬁndings suggest that when
SNARE-mediated membrane trafﬁcking is inhibited Src cannot transit
from the Rab11-containing endosome to participate in integrin-
dependent signaling in the cell periphery.
3.4. Inhibition of SNARE-mediated membrane trafﬁcking impairs FAK–Src
dependent signaling
FAK–Src signaling during adhesion has been linked to the
activation of several signaling pathways involved in cell spreading,
Fig. 2. E329Q-NSF inhibits phosphorylation of FAK and Src. A. CHO-E329Q cells were induced for 9 h (+) or mock treated (−) and serum-starved for the last hour, before being lifted,
held in suspension for 15 min (Susp) or plated on FN for the times indicated in the top row (which apply to all blots). Cells were lysed in situ using SDS sample buffer and analyzed for
the indicated phosphoproteins by SDS-PAGE and Western blot with the indicated antibodies. FAK loading control is at the bottom. B. Blots were scanned and the intensities of
indicated phosphoproteins were quantiﬁed using ImageJ software. Data are presented as percent of maximal response. Mean±SD from at least 3 independent experiments is shown.
White bars are data from mock treated CHO-E329Q cells and black bars are data from induced cells.
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recruit and activate PI3K at the plasma membrane [21]; Src binding
and phosphorylation of Tyr861-FAK lead to recruitment and phos-
phorylation of p130Cas which initiates Rac signaling via the CrkII–
DOCK180–ELMO complex [22,23]. Having already shown that SNARE-
mediated membrane trafﬁcking is required for cell spreading,
migration and FA turnover [9–11], and that this is possibly due to
impaired FAK–Src complex formation, PI3K and Rac activation wereassessed, as these are key mediators of cell motility. PI3K activity and
PIP3 production were monitored by the phosphorylation of protein
kinase B (Akt) on Ser473, a well documented PI3K-dependent event
[24]. Initial adhesion to FN (15 and 30 min) rapidly induced Akt
phosphorylation in both control and mutant NSF-expressing cells
(Fig. 6A). As the cells adhered, Akt phosphorylation diminished, but
this occurred more rapidly in cells expressing E329Q-NSF. Next the
location of PIP3 was examined by expressing the PH domain of Akt
Fig. 3. SNAP23CΔ9 inhibits phosphorylation of FAK and Src. A. CHO-K1 cells were co-transfected with GFP-FAK and full-length SNAP23 (FL) or truncated SNAP23 (CΔ9) (10:1 molar
ratio, respectively) for 15 h and serum-starved for the last hour, before being lifted, held in suspension for 15 min (Susp) or plated on FN for the times indicated in the top row (which
apply to all blots). Cells were lysed in situ using SDS sample buffer and analyzed for the indicated phosphoproteins by SDS-PAGE and Western blot with the indicated antibodies.
Bands corresponding to GFP-FAK are shown and a representative blot re-probed for GFP as a loading control is at the bottom. B. Blots were scanned and the intensities of indicated
phosphoproteins were quantiﬁed using ImageJ software. Data are presented as percent of maximal response. Mean±SD from at least 3 independent experiments is shown. White
bars are data from full-length SNAP23 co-expressing cells and black bars represent data from truncated SNAP23 co-expressing cells.
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primarily in the periphery, at the edge of the cell, with more diffuse
staining near the center of the cell (Fig. 6B). Detectable PIP3 in the cell
periphery noticeably diminished between 45 and 90 min of cell
spreading (Fig. 6C–D), coinciding with the decreased Akt phosphor-
ylation observed over this period (Fig. 6A). In E329Q-NSF-expressing
cells, PIP3 localization was more diffuse with no signiﬁcant accumu-
lation at the peripheral edge of the cell (Fig. 6E). Consistent with
reduced Akt phosphorylation, detectable PIP3 at the cell periphery
declined more rapidly in E329Q-NSF-expressing cells than in control
cells (Fig. 6F–G). These ﬁndings support the notion that SNARE-
mediated membrane trafﬁcking of Src is required for efﬁcient
activation and/or targeting of PI3K.
During adhesion, Rac activity was monitored both by pull-down of
RacGTP with the CRIB-domain from PAK and by assessing membrane
association of Rac. As shown previously, Rac was rapidly loaded
(15 min time point) with GTP upon adhesion to FN in control cells and
this decreased as they spread [25] (Fig. 7A). In E329Q-NSF-expressing
cells, the level of RacGTP was signiﬁcantly reduced. This phenotype
was also observed when membrane-associated Rac was examined,with less Rac bound to membranes in E329Q-NSF-expressing cells
compared to controls (Fig. 7B).
3.5. Membrane-targeted Src-CAAX and PI3K-CAAX rescue cell spreading
and focal adhesion turnover in cells with impaired SNARE function
We have previously attempted to restore cell spreading and normal
FA size in cells with impaired SNARE-mediated trafﬁc using constitu-
tively active Rac1-Q61L, dominant-negative RhoA-T19N, and by
inhibiting ROCK with Y27632 [11]. In these cases, Rac1-Q61L increased
cell spreading, but did not restore normal FA size; the ROCK inhibitor
disrupted FA formation and/or promoted turnover, but did not restore
lamellipodium formation; RhoA-T19Nhadnoeffect. Having shownhere
that SNARE-dependent trafﬁcking is required for FAK–Src complex
activation,we sought to reverse the effects of E329Q-NSF bymodulating
signaling more proximal to integrins. Initially, we attempted to restore
cell spreading and FA turnover by over-expressing wild-type (SrcWT)
and a constitutively active C-terminal deletion of Src (SrcCA) with
E329Q-NSF; however, while SrcCA did increase spreading when
expressedwithwtNSF, both SrcWT and SrcCA failed to rescue spreading
Fig. 4. Inhibition of SNARE-mediated membrane trafﬁc inhibits the interaction of FAK and Src. A. CHO-E329Q cells were induced for 9 h (+) or mock treated (−) and serum-starved
for the last hour, before being lifted, held in suspension for 15 min (Susp) or plated on FN for the indicated times. Cell lysates were then prepared in situ, pre-cleared and FAK was
immunoprecipitated with anti-FAK-protein G-Sepharose beads. Immunoprecipitates were washed and analyzed by SDS-PAGE and Western blots for Src (upper blot) followed by
stripping and re-probing for FAK (lower blot). B. CHO-K1 cells were co-transfected with full-length SNAP23 (FL) or truncated SNAP23 (CΔ9) along with GFP-FAK (10:1 molar ratio,
respectively) for 15 h, serum-starved for the last hour, lifted, and held in suspension for 15 min (Susp) or plated on FN for the indicated times. Cell lysates were then prepared in situ,
pre-cleared and GFP-FAK was immunoprecipitated with anti-GFP-protein G-Sepharose beads. Immunoprecipitates were analyzed by SDS-PAGE and Western blots for Src (upper
blot) and FAK (lower blot). The lower band in the Src blot is the IgG heavy chain (IgG hc).
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that in E329Q-NSF-expressing cells the majority of membrane-
associated SrcWT and SrcCA failed to trafﬁc to the plasma membrane
and were trapped in a perinuclear Rab11-containing compartment
(data not shown; Supplementary Fig. 2, respectively).
We hypothesized that a form of Src that was constitutively
targeted to the plasma membrane would support cell spreading and
FA signaling in a manner that was not dependent on SNARE-mediated
trafﬁc. We therefore generated a Src construct containing the CAAX
domain from k-Ras (Src-CAAX), which targets Src to the plasma
membrane and transfected this into cells along with E329Q-NSF. Cells
expressing Src-CAAX that were also transfected with E329Q-NSF
spread similarly to wtNSF-expressing control cells (Fig. 8A). We did
observe an increase in cell spreading, above that observed in control
cells, as a result of Src-CAAX expression and speculate that this may be
attributable to enhanced Src-FAK signaling resulting from increased
levels of Src at the plasma membrane. Expression of Src-CAAX also
reversed the deﬁcit in cell spreading that was caused by expression of
SNAP23CΔ9 (Fig. 8B). To determine if Src-CAAX expression could
restore normal FA size in cells with impaired SNARE function, we
expressed Src-CAAX along with E329Q-NSF or SNAP23CΔ9 in cells and
measured FA size as in Fig. 1. In cells expressing E329Q-NSF (Fig. 9A)
or SNAP23CΔ9 (Fig. 9B), Src-CAAX restored FA size to that of control
cells. These results suggest that the transport of Src, to the plasma
membrane, is required for normal cell spreading and FA signaling.
To test the possibility that PI3K is functioning downstream of
SNARE-mediated trafﬁcking of Src, a membrane-targeted catalytic
(p110α) subunit of PI3K (PI3K-CAAX) was transiently over-expressed
in cells in which E329Q-NSF expression could be induced or which
were co-transfected with either SNAP23FL or SNAP23CΔ9. When the
PI3K-CAAX construct is over-expressed it serves as a constitutively
active PI3K [12]. Using PH-Akt-RFP as a reporter, it was observed that
PI3K-CAAX restored PIP3 production at the cell periphery as expected(data not shown). PI3K-CAAX expression also restored cell spreading
(lamellipodium extension) to control levels in cells expressing
E329Q-NSF without having a signiﬁcant effect on spreading in cells
expressing wild-type NSF (Fig. 8A). A similar effect of PI3K-CAAX was
observed in cells expressing SNAP23CΔ9 (Fig. 8B). Consistent with
these observations, the size of FAs was reduced to wild-type levels
when PI3K-CAAXwas expressed in cells also expressing either E329Q-
NSF (Fig. 9A) or SNAP23CΔ9 (Fig. 9B).
4. Discussion
The present study demonstrates that in CHO-K1 cells SNARE-
mediated membrane trafﬁc is needed for efﬁcient translocation of Src
from a Rab11-containing compartment to the cell periphery. At the
plasma membrane, Src facilitates integrin-dependent signaling leading
to cell spreading and FA turnover. When membrane trafﬁcking was
inhibited with dominant-negative NSF (E329Q-NSF) or truncated
SNAP23 (SNAP23cΔ9), Src trafﬁcking out of the recycling endosome
was impeded. This meant that although FAK was recruited to FAs and
autophosphorylated on Tyr397, creating a high afﬁnity SH2-binding
site, Src was unable to bind FAK. A delay was observed in Tyr397-
phosphorylation early during adhesion in cells expressing E329Q-NSF,
possibly resulting from reduced delivery of integrins to the plasma
membrane as described previously [10,26,27]; however, this delay did
not appear to be a primary cause of the defects in spreading and FA
turnover observed here. The latter assertion is based on the fact that at
later time points of adhesion (after 30 min) phosphorylation of FAK
Tyr397 had recovered (Fig. 2), but FAK–Src binding and Akt activation
remained impaired. Furthermore, in cells expressing SNAP23cΔ9,
phosphorylation of FAK Tyr397 was not perturbed (Fig. 3), yet FAK–
Src binding, cell spreading and focal adhesion turnover were decreased.
During cell adhesion, the Src SH2-domain normally binds phos-
phorylated Tyr397 of FAK, relieving an autoinhibitory conformation in
Fig. 5. Inhibition of SNARE-mediated membrane trafﬁc inhibits Src trafﬁcking from a Rab11 compartment. CHO-E329Q cells were mock treated (Wild-type NSF; A–C, G–I) or induced
with doxycycline (E329Q-NSF; D–F, J–L) for 9 h and serum-starved for the last hour, before being lifted, and plated on FN for the indicated times. Cells were ﬁxed in ice-cold 0.1%
Triton X-100, 2% paraformaldehyde and stained with anti-Src (red; A, D, G, and J) and anti-Rab11 (green; B, E, H, and K). Arrowheads point to Src-Rab11-containing compartment in
WT-NSF cells (I) and E329Q-NSF cells (L). Note the increased amount of Src in Rab11-containing compartment in L. Scale bar=10 μm. (M) Cells from the above experiments, as well
as untreated cells, and cells where membrane trafﬁc was inhibited with truncated SNAP23 (SN23CΔ9) and dominant-negative Rab11 (Rab11S25N) were visually scored as having
primarily perinuclear Src staining (light grey bars), as seen in panel A, or peripheral Src staining (dark grey bars), as seen in panel G. Results are themeans±SEM of at least 3 separate
experiments in which at least 50 cells were scored.
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loop. In cells where membrane trafﬁc was inhibited with E329Q-NSF,
Src-Tyr416 phosphorylation was inhibited, consistent with a require-
ment for Src to be translocated for it to beactivated. Furthermore,within
the FAK–Src complex, Src has been shown to trans-phosphorylate
FAK at Try576/577 within the kinase activation domain, and within the
C-terminus at Tyr861 and Tyr925 [1]. These Src-dependent phosphor-
ylations were decreased when membrane trafﬁcking was impaired
through inhibition of either NSF or SNAP23. The similarity of theobserved effects on FAK signaling resulting from inhibition of membrane
trafﬁc in general (E329Q-NSF) or from targeting of SNAP23 (SNAP23cΔ9)
suggests that a subset of SNARE-mediated pathways (involving SNAP23)
contributes to this signaling mechanism. We are currently working
to identify the other SNAREs that collaborate with SNAP23 in this
pathway.
The decreased phosphorylation of FAK at Tyr861 and Tyr925 likely
has important implications for the observed deﬁciencies in cell
spreading and FA turnover. Phosphorylation of Tyr861 is associated
Fig. 6. E329Q-NSF inhibits phosphorylation of Akt and reduces peripheral PIP3. CHO-E329Q cells were induced for 9 h (+), or mock treated (−), serum-starved for the last hour,
lifted and held in suspension for 15 min (Susp) or plated on FN for the indicated times. A. Cells were lysed in situ using SDS sample buffer and analyzed for phosphorylated Ser473-Akt
by SDS-PAGE and Western blot using a phosphospeciﬁc antibody (upper blot). The membrane was stripped and re-probed for total AKT (lower blot). B–G. CHO-E329Q cells were
transfected with a RFP-tagged form of the PH domain from Akt (PH-Akt-RFP). After 6 h, cells were induced for 9 h (E329Q-NSF; E–G), or mock treated (Wild-type NSF; B–D), serum-
starved for the last hour, lifted, and plated on FN (20 μg/mL) for the indicated times. Cells were then ﬁxed in ice-cold 0.1% Triton X-100, 2% paraformaldehyde, washed, mounted and
imaged by confocal microscopy. Scale bar=10 μm.
Fig. 7. Inhibition of SNAREs impairs activation of Rac. CHO-E329Q cells were induced for 9 h (+), or mock treated (−), serum-starved for the last hour, lifted and held in suspension
for 15 min (Susp) or plated on FN for the indicated times. A. Cell lysates were prepared in situ, pre-cleared and incubated with CRIB-domain-labeled Sepharose beads. As positive and
negative controls, respectively, lysates from cells plated for 90 min were incubated with GTPγS, or GDP, during the RacGTP pull-down. RacGTP was eluted with SDS sample buffer
and analyzed by SDS-PAGE andWestern blot. B. Cells were lysed in hypotonic lysis buffer, collected by scraping and homogenized. Lysates were cleared to remove unbroken cells and
supernatants were ultracentrifuged to collect a membrane fraction. Membrane fractions were analyzed by SDS-PAGE andWestern blot for Rac1 and β1-integrin as a loading control.
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Fig. 8. A plasmamembrane-targeted Src or p110α-subunit of PI3K rescue cell spreading
in cells expressing E329Q-NSF and truncated SNAP23. A. CHO-K1 cells were transfected
with wild-type (WT-NSF) or dominant-negative NSF (E329Q-NSF), along with control
vector, wild-type Src (SrcWT), constitutively active Src (SrcCA), membrane-targeted
Src (Src-CAAX) or PI3K-CAAX for 9 h, lifted and plated onto FN-coated coverslips
(20 μg/mL) for 90 min, ﬁxed and stained for NSF or Src, and actin to allow assessment of
lamellipodium extension. The results are presented as percent of untransfected control
cells. B. CHO-K1 cells were co-transfected with full-length GFP-SNAP23 (SNAP23FL) or
truncated GFP-SNAP23 (SNAP23CΔ9), and Src-CAAX, PI3K-CAAX or control vector (1:10
molar ratio, respectively) for 15 h. Cells were lifted and plated on FN and lamellipodium
extension analyzed as in A. In A and B, at least 20 randomly selected transfected cells
were analyzed per condition for each experiment; means±SEM of at least three
independent experiments are shown.
Fig. 9. A plasma membrane-targeted Src or p110α-subunit of PI3K rescue focal adhesion
turnover in cells expressing E329Q-NSF. A. CHO-E329Q cells were co-transfectedwith Src-
CAAX, PI3K-CAAX or control vector, along with GFP-paxillin (10:1 molar ratio,
respectively), followed by induction of E329Q-NSF (E329Q-NSF) or mock treatment
(WT-NSF) for 9 h. Cellswere lifted and plated on FN (10 μg/mL) for 2 h, followed by ﬁxing,
mounting and analysis by confocal microscopy to document and measure focal adhesion
size. B. CHO-K1 cellswere co-transfectedwith Src-CAAX, PI3K-CAAX or control vector, and
FLAG-SNAP23 full-length (SNAP23FL) or FLAG-SNAP23 truncated (SNAP23CΔ9), along with
GFP-paxillin (10:1:1 molar ratio, respectively) for 15 h. Cells were lifted and plated on FN
(10 μg/mL) for 2 h, followed by ﬁxing, staining for FLAG, and analysis of focal adhesions as
inA. InA andB, at least 10 randomly selected transfected cellswere analyzedper condition
for each experiment; means±SEM of at least three independent experiments are shown.
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facilitates tyrosine phosphorylation of p130Cas and recruitment of a
CrkII–DOCK180–ELMO complex which regulates Rac1 signaling
[22,23]. As was demonstrated during inhibition of membrane trafﬁc,
Rac activity and membrane association were reduced. In a previous
study, expression of a constitutively active Rac1-Q61L was able to
overcome the inhibition in spreading, but FAs remained larger [11].
The present study suggests that the larger FAs result from reduced FA
turnover, possibly due to decreased FAK–Tyr925 phosphorylation.
Several studies have shown that phosphorylation of FAK at Tyr925 is
required for FA turnover. When Tyr925 is phosphorylated, it creates
the SH2-binding site for Grb2, which overlaps with the paxillin-
binding FAT domain, and consequently binding of Grb2 may displace
paxillin from FAK leading to FAK dissociation and FA turnover [28,29].
Tyr925-phosphorylated FAK appears to be excluded from FAs, and
expression of a Try925Phe mutant results in larger FAs and less
turnover [30]. Similarly, Grb2may recruit dynamin to FAK leading to a
dynamin-dependent FA turnover [31].
Although we did not directly measure FAK kinase activity here, the
fact that phosphorylation at both FAK–Tyr576 and Src-Tyr416 were
reduced is consistent with reduced cellular FAK activity. It is therefore
reasonable to speculate that many signaling pathways dependent on
FAK–Src activity, and leading to spreading and FA turnover, might be
perturbed. For example, the FAK–Src complex has been implicated inthe phosphorylation of paxillin at Tyr31 and Tyr118 which recruits
CrkII–DOCK180–ELMO promoting Rac-dependent spreading [32,33].
When these residues in paxillin are mutated to non-phosphorylatable
amino acids, the turnover of FAs is inhibited [34]. Also, FAK–Src
phosphorylation of GIT2 recruits a GIT2–PIX–PAK complex to paxillin
implicated in Rac activation [35,36]. Furthermore, a similar GIT1–PIX–
PAK–paxillin complex has been implicated not only in Rac activation,
but also FA turnover [37].
The proposal that SNARE-mediated trafﬁcking of Src to the plasma
membrane is required for FAK–Src interaction and focal adhesion
turnover is supported by the observation that expression of plasma
membrane-targeted Src-CAAX reversed the effects that inhibiting
SNARE function had on cell spreading and FA size. This notion is
underscored by the demonstration that a constitutively active Src
(SrcCA) did not rescue spreading. The SrcCA did remain associated
with a Rab11-containing compartment in E329Q-NSF-expressing cells
(Supplementary Fig. 2), indicating that the translocation of this
construct is SNARE-dependent and thus the constitutive activity of
SrcCA is mitigated by the fact that it is not properly transportedwithin
the cell. Recent studies have documented the translocation of Src from
a perinuclear compartment to the plasma membrane under several
conditions, including reports showing that this translocation is
dependent on membrane trafﬁc [6,38]. In agreement with results
shown here, Sandilands et al. [5] found that expression of a dominant-
negative mutant of Rab11 inhibited translocation of Src to the plasma
membrane [5]. It is not yet known how speciﬁc SNARE and Rab family
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rently underway to investigate this pathway.
While we have focused on the trafﬁcking of Src here, we cannot
exclude the possibility that other protein(s) are trafﬁcked along with
Src from a recycling endosome and subsequently inﬂuence integrin
signaling. Previously, we have shown that inhibition of SNARE-mediated
membrane trafﬁc impairs the delivery of α5β1-integrin from a Rab11
compartment similar to the one observed here [10]. It is interesting to
speculate that integrin and Src may be trafﬁcking as part of a complex to
the plasma membrane and future studies will address this possibility.
The ﬁnding that a plasma membrane-targeted p110α-subunit of
phosphatidylinositol 3-kinase (PI3K-CAAX) rescued spreading and FA
turnover in cells with impaired SNARE function suggests a mechanistic
role for SNARE-mediated trafﬁc in regulating FAK–Src signaling. In the
context of cell adhesion and spreading, it has been proposed that
binding of the SH2 domain of p85-PI3K to Tyr397-phosphorylated FAK
results in recruitment and phosphorylation of PI3K [21]. Alternatively, a
set of studies has also shown that β1-integrins can activate PI3K in a
FAK/Src-independent pathway and this pathway can lead to p130Cas
phosphorylation [39,40], indicating that Src is not absolutely required
for PI3K activity. Here, we observed that PI3K/Akt can be activated
independently of Src trafﬁcking at early time points (Fig. 6A); however,
Src or some other SNARE-dependent component is required for
sustained activity after 45 min of adhesion and for proper localization
of PI3K. Several studies have implicated Src in PI3K/Akt activation [41]
and this activation of PI3K can contribute to regulation of actin
cytoskeleton remodeling [42,43]. Constitutive targeting of PI3K-CAAX
tomembranes, as used herein, may bypass this SNARE-dependent form
of Src signaling andmay lead to Rac activation and spreading via several
mechanisms [44]. PI3K/PIP3 has also been implicated directly in FA
turnover, providing another plausible mechanism by which PI3K-CAAX
might bypass Src and stimulate FA turnover [45–47].
FAK and Src are central regulators of cell–ECM adhesion. Impor-
tantly, both these proteins have well described roles in cancer
progression and metastasis, prompting the study of small molecule
inhibitors of these proteins in cancer treatment. The results described in
the present study reveal that SNARE-mediated membrane trafﬁc has a
potent inﬂuence over FAK–Src signaling and may contribute to the
development of new therapeutic strategies.
Supplementary data to this article can be found online at
doi:10.1016/j.bbamcr.2010.09.008.
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